Billions of heat exchangers are in use around the world. These devices, whose purpose is to transfer heat between fluids, are ubiquitous across many commonplace applications: they appear in HVAC systems, refrigerators, cars, ships, aircraft, wastewater treatment facilities, cell phones, data centers, and petroleum refining operations, among many other settings.
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have recently gained attention for their effectiveness in managing weight gain, high blood sugar, and even reducing alcohol cravings.
A new clinical trial, co-led by endocrinologist and diabetes specialist John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine, has demonstrated that the oral form of semaglutide significantly lowers the risk of cardiovascular events in individuals with type 2 diabetes, atherosclerotic cardiovascular disease.
Cardiovascular disease (CVD) encompasses a range of disorders affecting the heart and blood vessels, including coronary artery disease, heart attack, stroke, and hypertension. These conditions are primarily driven by atherosclerosis, a process where plaque builds up in the arterial walls, leading to narrowed or blocked arteries. Risk factors include smoking, unhealthy diet, lack of exercise, obesity, and genetic predisposition. CVD remains a leading cause of global mortality, emphasizing the importance of lifestyle changes, medical interventions, and preventive measures in managing and reducing the risk of heart-related illnesses.
New system lets drones autonomously perform complex aerobatics, safely outmaneuvering humans in both indoor and outdoor settings.
An innovation by a collaboration of US and Chinese scientists achieved nearly 100% voltage recovery in aging lithium-ion batteries.
A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body. Scientists at Duke University School of Medicine, University of Texas Health Science Center at San Antonio, and University of Arkansas have found a way to improve the uptake of a promising class of cancer-fighting drugs called PROTACs, which have struggled to enter cells due to their large size.
The new method works by taking advantage of a protein called CD36 that helps pull substances into cells. By designing drugs to use this CD36 pathway, researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.
Data from mouse studies shows this enhanced uptake led to stronger tumor suppression without making the drugs harder to dissolve or less stable.
Human high-order thalamic nuclei activity is known to closely correlate with conscious states. However, it is not clear how those thalamic nuclei and thalamocortical interactions directly contribute to the transient process of human conscious perception…
A study by researchers from the University of British Columbia’s Blusson Quantum Matter Institute (UBC Blusson QMI) has found a rare form of one-dimensional quantum magnetism in the metallic compound Ti4MnBi2, offering evidence into a phase space that has remained, until now, largely theoretical.
The study, published in Nature Materials, comes at a time of growing global interest in quantum materials that redefine the boundaries between magnetism, conductivity, and quantum coherence.
“We proved the existence of a new class of quantum materials that are both metallic and one-dimensional magnets, with strong coupling between the magnetic moments and their metallic host,” said UBC Blusson QMI Investigator Prof. Meigan Aronson.
Google on Monday announced plans that might help a scientific breakthrough in research into the communication patterns of dolphins. The tech giant announced that it would make DolphinGemma, its foundational AI model, accessible to researchers over the summer.
